REGN-5381
- Generic Name
- REGN-5381
REGN5381 in Adult Participants With Uncontrolled Hypertension
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 732
- Registration Number
- NCT06833190
- Locations
- 🇬🇧
Protas, Car Park of Asda Pilsworth Road, Bury, United Kingdom
🇬🇧Protas, Car Park of Asda Huyton Supercentre, Huyton, Liverpool, United Kingdom
🇬🇧Protas, Two New Bailey Square, Salford, Manchester, United Kingdom
REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 391
- Registration Number
- NCT06237309
- Locations
- 🇪🇸
Hospital Universitario Virgen Macarena Unidad Coronaria 1 planta, Sevilla, Spain
🇵🇱Wojewodzki Szpital Zespolony - Ludwik Rydygier Provincial Hospital, Torun, Kuyavian-Pomeranian, Poland
🇵🇱UCK Medical University of Warsaw, Warszawa, Mazowieckie, Poland
REGN5381 in Heart Failure Adult Participants With Elevated Pulmonary Capillary Wedge Pressure
- Conditions
- Heart Failure
- Interventions
- Drug: Matching Placebo
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 59
- Registration Number
- NCT05353166
- Locations
- 🇲🇩
ARENSIA Exploratory Medicine at the Republican Clinical Hospital, Chișinău, Moldova, Republic of
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9035 in Healthy Adult Volunteers and Mildly Hypertensive Participants
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 93
- Registration Number
- NCT05291546
- Locations
- 🇧🇪
Universitair Ziekenhuis Leuven Gasthuisberg Campus, Leuven, Belgium
🇩🇪Charite Research Organisation GmbH, Berlin, Germany
Study to Assess the Safety, Tolerability, and Pharmacokinetics of REGN5381 (an NPR1 Agonist) in Adult Humans
- First Posted Date
- 2020-08-10
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 90
- Registration Number
- NCT04506645
- Locations
- 🇧🇪
Universitair Ziekenhuis Leuven Gasthuisberg Campus, Leuven, Belgium
🇧🇪Ghent University, Ghent, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.